연구동향 분석

Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB

Wulphert Venderink Sjoerd FM Jenniskens JP Michiel Sedelaar Tsutomu Tamada Jurgen J F?tterer 2018년

논문상세정보
인용/피인용

' Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB' 의 참고문헌

  • Transperineal in-bore 3-T MR imagingguided prostate biopsy: a prospective clinical observational study
    Penzkofer T [2015]
  • Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device
    Sonn GA [2013]
  • Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required
  • Results of targeted biopsy in men with magnetic resonance imaging lesions classified equivocal, likely or highly likely to be clinically significant prostate cancer
    Venderink W [2017]
  • Relationship between prebiopsy multiparametric magnetic resonance imaging (MRI), biopsy indication, and MRI-ultrasound fusion-targeted prostate biopsy outcomes
    Meng X [2016]
  • Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software
    Le Nobin J [2014]
  • Prostate cancer diagnosis on repeat magnetic resonance imaging-transrectal ultrasound fusion biopsy of benign lesions: recommendations for repeat sampling
    Chelluri R [2016]
  • Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System Score
    Osses DF [2017]
  • Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound- guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies
    Pokorny MR [2014]
  • Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies
    Arsov C [2015]
  • Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies
  • Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard
  • PI-RADS prostate imaging - reporting and data system: 2015, version 2
    Weinreb JC [2016]
  • Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer
  • Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen
    Hambrock T [2010]
  • MRI-guided in-bore biopsy: differences between prostate cancer detection and localization in primary and secondary biopsy settings
  • In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer
    Felker ER [2016]
  • Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla
    Roethke MC [2014]
  • Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
    Ahmed HU [2017]
  • Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer
    Siddiqui MM [2015]
  • Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of in-bore versus magnetic resonance imaging- transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique?
    Wegelin O [2017]
  • Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature
    Futterer JJ [2015]
  • An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-preliminary experience
    Costa DN [2017]
  • A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy
    Baco E [2016]